Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Non Alcoholic steatohepatitis
Recent news which mentions Non Alcoholic steatohepatitis
Terns Reports Topline Results from Early-Stage NASH Study
March 22, 2022
Tickers
TERN
Tags
General
Benzinga
Non Alcoholic steatohepatitis
From
Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
January 25, 2022
Tickers
ETNB
Tags
News
Phase 1 Trial
Health Care
From
Benzinga
Why Are Intercept Pharmaceuticals Shares Falling Today?
December 09, 2021
Tickers
ICPT
Tags
Non Alcoholic steatohepatitis
Phase 3 Trial
Benzinga
From
Benzinga
Inventiva Posts Results of Clinical Thorough QT Study Of Lanifibranor
December 07, 2021
Tickers
IVA
Tags
Biotech
Benzinga
Non Alcoholic steatohepatitis
From
Benzinga
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
November 23, 2021
Tickers
ARWR
GSK
Tags
General
Briefs
Biotech
From
Benzinga
Terns' Potential NASH Candidate Shows Potent Liver Target Engagement
November 10, 2021
Tickers
TERN
Tags
General
Movers
Biotech
From
Benzinga
Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement
November 08, 2021
Tickers
GLMD
Tags
fibrosis
News
Health Care
From
Benzinga
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
November 02, 2021
Tickers
LLY
MTCR
Tags
Non Alcoholic steatohepatitis
Benzinga
Biotech
From
Benzinga
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
November 01, 2021
Tickers
GLMD
Tags
Benzinga
Non Alcoholic steatohepatitis
Phase 3 Trial
From
Benzinga
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
October 28, 2021
Tickers
IVA
LLY
Tags
Phase 2 Trial
Small Cap
General
From
Benzinga
Axcella To Test NASH Candidate In Long COVID Patients
October 26, 2021
Tickers
AXLA
Tags
Penny Stocks
Trading Ideas
AXLA
From
Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
October 04, 2021
Tickers
ENTA
Tags
Market News
Health Care
Trading Ideas
From
Benzinga
Fast Track Status Expanded For Inventiva's NASH Treatment
September 22, 2021
Tickers
IVA
Tags
Market News
News
IVA
From
Benzinga
Hepion Pharma Shares Encouraging Biomarker Data From NASH Trial
September 13, 2021
Tickers
HEPA
Tags
Market News
HEPA
Trading Ideas
From
Benzinga
Why Are Hepion Pharma Shares Moving Higher Premarket Monday?
September 13, 2021
Tickers
HEPA
Tags
Trading Ideas
HEPA
Penny Stocks
From
Benzinga
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
August 25, 2021
Tickers
LPCN
Tags
Market News
Penny Stocks
Trading Ideas
From
Benzinga
Siemens' Fatty Liver Disease Blood Test Wins FDA De Novo Clearance
August 24, 2021
Tickers
GILD
SMMNY
Tags
General
SMMNY
FDA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.